Effects of liver disease and of aging on the disposition and elimination of sedatives.
D000375:Aging; D014151:Anti-Anxiety Agents / Q000378:metabolism*; D002707:Chlordiazepoxide / Q000378:metabolism; D002746:Chlorpromazine / Q000378:metabolism; D003975:Diazepam / Q000378:metabolism; D006207:Half-Life; D006525:Hepatitis, Viral, Human / Q000378:metabolism; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D008140:Lorazepam / Q000378:metabolism; D008620:Meprobamate / Q000378:metabolism; D010076:Oxazepam / Q000378:metabolism
D014151:Anti-Anxiety Agents; D010076:Oxazepam; D002707:Chlordiazepoxide; D008620:Meprobamate; D008140:Lorazepam; D003975:Diazepam; D002746:Chlorpromazine